Oruka Therapeutics, Inc. (ORKA): Total Liabilities
$16.69M
As of 2025-12-31
$24.84M
As of 2026-06-30
+127.8%
3-year compound annual growth
+33.7%
5-year compound annual growth
+27.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.69M | +20.9% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $13.80M | n/m | 2026-03-12, Balance as of period end |
| 2023-12-31 | $841.0K | -40.4% | 2024-02-01, Balance as of period end |
| 2022-12-31 | $1.41M | -63.6% | 2024-02-01, Balance as of period end |
| 2021-12-31 | $3.88M | -0.7% | 2023-02-24, Balance as of period end |
| 2020-12-31 | $3.91M | +322.0% | 2022-03-14, Balance as of period end |
| 2019-12-31 | $926.0K | +16.8% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $793.0K | -62.1% | 2019-02-27, Balance as of period end |
| 2017-12-31 | $2.09M | -14.2% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $2.44M | +61.9% | 2018-03-22, Balance as of period end |
| 2015-12-31 | $1.50M | +8.1% | 2017-03-21, Balance as of period end |
| 2014-12-31 | $1.39M | -7.5% | 2016-03-17, Balance as of period end |
| 2013-12-31 | $1.50M | +392.8% | 2015-03-19, Balance as of period end |
| 2012-12-31 | $305.0K | -60.4% | 2014-03-20, Balance as of period end |
| 2011-12-31 | $770.0K | -44.4% | 2013-03-21, Balance as of period end |
| 2010-12-31 | $1.39M | n/a | 2012-03-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | 2025-12-31 | $16.69M | +20.9% |
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | $161.76M | +37.5% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | $210.17M | -7.7% |
| MapLight Therapeutics, Inc. (MPLT) | 2025-12-31 | $21.14M | -2.7% |
| Enliven Therapeutics, Inc. (ELVN) | 2025-12-31 | $16.57M | +4.1% |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | $334.65M | +27.5% |
| Rapport Therapeutics, Inc. (RAPP) | 2025-12-31 | $27.78M | +192.2% |
| Rigel Pharmaceuticals Inc (RIGL) | 2025-12-31 | $122.11M | -24.0% |
| Biohaven Ltd. (BHVN) | 2025-12-31 | $399.38M | +108.4% |
Compare ORKA, VNDA, RYTM, MPLT side by side · Screen every company in Pharmaceutical Preparations ↗